Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Mesenchymal Stem Cells-Derived Exosomes by AbelZeta for Acute Respiratory Distress Syndrome: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by AbelZeta and currently in Phase II for Acute Respiratory Distress Syndrome....
Data Insights
Mesenchymal Stem Cells-Derived Exosomes by CellTex Therapeutics for Alzheimer's Disease: Likelihood of Approval
Mesenchymal Stem Cells-Derived Exosomes is under clinical development by CellTex Therapeutics and currently in Phase I for Alzheimer's Disease. According...